{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:48:14Z","timestamp":1787730494828,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01800-1","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:35:11Z","timestamp":1761892511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated bioinformatics analysis reveals novel PANoptosis biomarkers and therapeutic response in clear cell renal cell carcinoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Bin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengpan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"5","key":"1800_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529\u201342.","journal-title":"Eur Urol"},{"issue":"9","key":"1800_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16(9):539\u201352.","journal-title":"Nat Rev Urol"},{"key":"1800_CR3","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1800_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1800_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.cdd.4400950","volume":"9","author":"JC Ameisen","year":"2002","unstructured":"Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 2002;9(4):367\u201393.","journal-title":"Cell Death Differ"},{"key":"1800_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094723","author":"LV Loftus","year":"2022","unstructured":"Loftus LV, Amend SR, Pienta KJ. Interplay between cell death and cell proliferation reveals new strategies for cancer therapy. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094723.","journal-title":"Int J Mol Sci"},{"key":"1800_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"key":"1800_CR8","doi-asserted-by":"crossref","unstructured":"Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Science immunology. 2016;1(2).","DOI":"10.1126\/sciimmunol.aag2045"},{"key":"1800_CR9","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641\u201357.","journal-title":"Comput Struct Biotechnol J"},{"key":"1800_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.omtn.2023.07.010","volume":"33","author":"X Yi","year":"2023","unstructured":"Yi X, Li J, Zheng X, Xu H, Liao D, Zhang T, et al. Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy. Mol Ther Nucleic Acids. 2023;33:376\u201390.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1800_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109019","volume":"238","author":"H Pan","year":"2022","unstructured":"Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol. 2022;238: 109019.","journal-title":"Clin Immunol"},{"issue":"7","key":"1800_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","volume":"34","author":"AA Ajibade","year":"2013","unstructured":"Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 2013;34(7):307\u201316.","journal-title":"Trends Immunol"},{"issue":"7","key":"1800_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4049\/immunohorizons.2100059","volume":"5","author":"RKS Malireddi","year":"2021","unstructured":"Malireddi RKS, Karki R, Sundaram B, Kancharana B, Lee S, Samir P, et al. Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth. ImmunoHorizons. 2021;5(7):568\u201380.","journal-title":"ImmunoHorizons"},{"issue":"12","key":"1800_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"1\u20132","key":"1800_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1\u20132):48\u201361.","journal-title":"Cell"},{"issue":"1","key":"1800_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-022-02431-0","volume":"41","author":"Z Gao","year":"2022","unstructured":"Gao Z, Xu J, Fan Y, Qi Y, Wang S, Zhao S, et al. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C\/EBP\u03b2 degradation to facilitate proneural-to-mesenchymal transition. J Exper Clinic Cancer Res: CR. 2022;41(1):223.","journal-title":"J Exper Clinic Cancer Res: CR"},{"issue":"2","key":"1800_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103257","volume":"22","author":"Y Li","year":"2023","unstructured":"Li Y, Liu H, Yan H, Xiong J. Research advances on targeted-Treg therapies on immune-mediated kidney diseases. Autoimmun Rev. 2023;22(2): 103257.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1800_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.kint.2020.08.028","volume":"99","author":"X Wang","year":"2021","unstructured":"Wang X, Lopez R, Luchtel RA, Hafizi S, Gartrell B, Shenoy N. Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. Kidney Int. 2021;99(1):75\u201385.","journal-title":"Kidney Int"},{"key":"1800_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.2648","author":"CG Drake","year":"2018","unstructured":"Drake CG, Stein MN. The immunobiology of kidney cancer. J Clin Oncol. 2018. https:\/\/doi.org\/10.1200\/JCO.2018.79.2648.","journal-title":"J Clin Oncol"},{"key":"1800_CR20","doi-asserted-by":"crossref","unstructured":"Lucarelli G, Lasorsa F, Milella M, d'Amati A, Ingravallo G, Silecchia M, et al. Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma. Urologic oncology. 2025.","DOI":"10.1016\/j.eururo.2025.09.3778"},{"issue":"4","key":"1800_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14737159.2023.2195553","volume":"23","author":"NA di Meo","year":"2023","unstructured":"di Meo NA, Lasorsa F, Rutigliano M, Milella M, Ferro M, Battaglia M, et al. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery. Expert Rev Mol Diagn. 2023;23(4):297\u201313.","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"1800_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli G, Loizzo D, Franzin R, Battaglia S, Ferro M, Cantiello F, et al. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma. Expert Rev Mol Diagn. 2019;19(5):397\u201307.","journal-title":"Expert Rev Mol Diagn"},{"key":"1800_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214360","author":"NA di Meo","year":"2022","unstructured":"di Meo NA, Lasorsa F, Rutigliano M, Loizzo D, Ferro M, Stella A, et al. Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232214360.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1800_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/1873-3468.14531","volume":"597","author":"S De Marco","year":"2023","unstructured":"De Marco S, Torsello B, Minutiello E, Morabito I, Grasselli C, Bombelli S, et al. The cross-talk between Abl2 tyrosine kinase and TGF\u03b21 signalling modulates the invasion of clear cell renal cell carcinoma cells. FEBS Lett. 2023;597(8):1098\u2013113.","journal-title":"FEBS Lett"},{"issue":"69","key":"1800_CR25","doi-asserted-by":"publisher","first-page":"113502","DOI":"10.18632\/oncotarget.23056","volume":"8","author":"C Bianchi","year":"2017","unstructured":"Bianchi C, Meregalli C, Bombelli S, Di Stefano V, Salerno F, Torsello B, et al. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation. Oncotarget. 2017;8(69):113502\u201315.","journal-title":"Oncotarget"},{"key":"1800_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/diseases4010007","author":"R Ragone","year":"2016","unstructured":"Ragone R, Sallustio F, Piccinonna S, Rutigliano M, Vanessa G, Palazzo S, et al. Renal cell carcinoma: a study through NMR-based metabolomics combined with transcriptomics. Diseases. 2016. https:\/\/doi.org\/10.3390\/diseases4010007.","journal-title":"Diseases"},{"issue":"15","key":"1800_CR27","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.18632\/oncotarget.3823","volume":"6","author":"G Lucarelli","year":"2015","unstructured":"Lucarelli G, Galleggiante V, Rutigliano M, Sanguedolce F, Cagiano S, Bufo P, et al. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. Oncotarget. 2015;6(15):13371\u201386.","journal-title":"Oncotarget"},{"issue":"12","key":"1800_CR28","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.18632\/aging.101685","volume":"10","author":"G Lucarelli","year":"2018","unstructured":"Lucarelli G, Rutigliano M, Sallustio F, Ribatti D, Giglio A, Lepore Signorile M, et al. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma. Aging. 2018;10(12):3957\u201385.","journal-title":"Aging"},{"issue":"11","key":"1800_CR29","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.ajpath.2020.08.008","volume":"190","author":"S Bombelli","year":"2020","unstructured":"Bombelli S, Torsello B, De Marco S, Lucarelli G, Cifola I, Grasselli C, et al. 36-kDa annexin A3 isoform negatively modulates lipid storage in clear cell renal cell carcinoma cells. Am J Pathol. 2020;190(11):2317\u201326.","journal-title":"Am J Pathol"},{"key":"1800_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213968","author":"G Lucarelli","year":"2022","unstructured":"Lucarelli G, Rutigliano M, Loizzo D, di Meo NA, Lasorsa F, Mastropasqua M, et al. MUC1 tissue expression and its soluble form CA15-3 identify a clear cell renal cell carcinoma with distinct metabolic profile and poor clinical outcome. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232213968.","journal-title":"Int J Mol Sci"},{"key":"1800_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030315","author":"M Milella","year":"2024","unstructured":"Milella M, Rutigliano M, Lasorsa F, Ferro M, Bianchi R, Fallara G, et al. The role of MUC1 in renal cell carcinoma. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14030315.","journal-title":"Biomolecules"},{"key":"1800_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713179","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Cancer stem cells in renal cell carcinoma: origins and biomarkers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713179.","journal-title":"Int J Mol Sci"},{"key":"1800_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100717","author":"M Milella","year":"2025","unstructured":"Milella M, Rutigliano M, Pandolfo SD, Aveta A, Crocetto F, Ferro M, et al. The metabolic landscape of cancer stem cells: insights and implications for therapy. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14100717.","journal-title":"Cells"},{"issue":"10","key":"1800_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","volume":"9","author":"L Vuong","year":"2019","unstructured":"Vuong L, Kotecha RR, Voss MH, Hakimi AA. Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 2019;9(10):1349\u201357.","journal-title":"Cancer Discov"},{"issue":"6","key":"1800_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.urolonc.2019.01.025","volume":"37","author":"R Tamma","year":"2019","unstructured":"Tamma R, Rutigliano M, Lucarelli G, Annese T, Ruggieri S, Cascardi E, et al. Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment. Urologic oncology. 2019;37(6):355.","journal-title":"Urologic oncology."},{"key":"1800_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-016-0841-9","volume":"14","author":"M Gigante","year":"2016","unstructured":"Gigante M, Pontrelli P, Herr W, Gigante M, D\u2019Avenia M, Zaza G, et al. MiR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. J Transl Med. 2016;14:84.","journal-title":"J Transl Med"},{"issue":"8","key":"1800_CR37","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.18632\/aging.103169","volume":"12","author":"GS Netti","year":"2020","unstructured":"Netti GS, Lucarelli G, Spadaccino F, Castellano G, Gigante M, Divella C, et al. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. Aging. 2020;12(8):7585\u2013602.","journal-title":"Aging"},{"issue":"7","key":"1800_CR38","first-page":"461","volume":"35","author":"G Lucarelli","year":"2017","unstructured":"Lucarelli G, Rutigliano M, Ferro M, Giglio A, Intini A, Triggiano F, et al. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma. Urologic Oncol. 2017;35(7):461.","journal-title":"Urologic Oncol."},{"key":"1800_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216515","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242216515.","journal-title":"Int J Mol Sci"},{"key":"1800_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041071","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, di Meo NA, Rutigliano M, Milella M, Ferro M, Pandolfo SD, et al. Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041071.","journal-title":"Biomedicines"},{"key":"1800_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123574","author":"V Ghini","year":"2020","unstructured":"Ghini V, Laera L, Fantechi B, Monte FD, Benelli M, McCartney A, et al. Metabolomics to assess response to immune checkpoint inhibitors in patients with non-small-cell lung cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12123574.","journal-title":"Cancers (Basel)"},{"key":"1800_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054814","author":"G Lucarelli","year":"2023","unstructured":"Lucarelli G, Netti GS, Rutigliano M, Lasorsa F, Loizzo D, Milella M, et al. MUC1 expression affects the immunoflogosis in renal cell carcinoma microenvironment through complement system activation and immune infiltrate modulation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054814.","journal-title":"Int J Mol Sci"},{"key":"1800_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123888","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Cellular and molecular players in the tumor microenvironment of renal cell carcinoma. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12123888.","journal-title":"J Clin Med"},{"issue":"11","key":"1800_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21(11):678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1800_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239\u201357.","journal-title":"Br J Cancer"},{"issue":"9","key":"1800_CR46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19(9):971\u201392.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"1800_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139.","journal-title":"Nat Immunol"},{"issue":"1","key":"1800_CR48","first-page":"1","volume":"1872","author":"CB Zhou","year":"2019","unstructured":"Zhou CB, Fang JY. The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection. Biochimica et Biophysica Acta (BBA). 2019;1872(1):1\u201310.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"1800_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100.","journal-title":"Mol Cancer"},{"key":"1800_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00074","volume":"4","author":"ZS Guo","year":"2014","unstructured":"Guo ZS, Liu Z, Bartlett DL. Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity. Front Oncol. 2014;4: 74.","journal-title":"Front Oncol"},{"key":"1800_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136720","author":"R Karki","year":"2020","unstructured":"Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.136720.","journal-title":"JCI Insight"},{"issue":"1","key":"1800_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-022-00889-0","volume":"7","author":"JF Lin","year":"2022","unstructured":"Lin JF, Hu PS, Wang YY, Tan YT, Yu K, Liao K, et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct Target Ther. 2022;7(1):54.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1800_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109858","volume":"37","author":"R Karki","year":"2021","unstructured":"Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37(3): 109858.","journal-title":"Cell Rep"},{"issue":"1","key":"1800_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41467-018-02950-5","volume":"9","author":"FL Li","year":"2018","unstructured":"Li FL, Liu JP, Bao RX, Yan G, Feng X, Xu YP, et al. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis. Nat Commun. 2018;9(1):508.","journal-title":"Nat Commun"},{"issue":"3","key":"1800_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.13058","volume":"157","author":"MA Moreno Ayala","year":"2019","unstructured":"Moreno Ayala MA, Li Z, DuPage M. Treg programming and therapeutic reprogramming in cancer. Immunology. 2019;157(3):198\u2013209.","journal-title":"Immunology"},{"issue":"12","key":"1800_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41581-020-0316-3","volume":"16","author":"CM D\u00edaz-Montero","year":"2020","unstructured":"D\u00edaz-Montero CM, Rini BI, Finke JH. The immunology of renal cell carcinoma. Nat Rev Nephrol. 2020;16(12):721\u201335.","journal-title":"Nat Rev Nephrol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01800-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:03:31Z","timestamp":1764954211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01800-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1800"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01800-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"338"}}